Menu

Close

  1. Yokohama-shi Top Page
  2. Municipal Government Information
  3. Public Relations, Public Information, News
  4. Press release
  5. Economic Affairs Bureau
  6. Press release FY2018
  7. LIP. Yokohama Business Plan Formulation Support Seminar II Points for management and new business development of R&D-type companies-knowledges of success behind the failure of predecessors-

Here's the text.

LIP. Yokohama Business Plan Formulation Support Seminar II Points for management and new business development of R&D-type companies-knowledges of success behind the failure of predecessors-

Last Updated October 30, 2018

Press release materials

October 30, 2018

Economic Affairs Bureau Industrial Cooperation Promotion Division

Toshitaka Ito

Phone number: 045-671-2574

Fax: 045-664-4867

 In the health and medical field, LIP. Yokohama supports the steady commercialization of venture companies, small and medium-sized enterprises that challenge the creation of new technologies and products in the health and medical fields. This seminar will be held free of charge for current managers and venture capitalists to give advice on typical failure experiences in the past, the background, causes, methods of avoidance, and management advice at R&D-type companies.
 By learning about actual failure cases that have occurred in the past of successful companies, it is an opportunity to deepen their understanding of the need for prior planning and strategy reviews to avoid them. We look forward to the participation of many companies interested in the health and medical field.

In order to open PDF files, you may need a separate PDF reader.
If you do not have it, you can download it free of charge from Adobe.
Get Adobe Acrobat Reader DCTo download Adobe Acrobat Reader DC

For inquiries to this page

Economic Affairs Bureau Startup Innovation Promotion Office

Phone: 045-671-4600

Phone: 045-671-4600

Fax: 045-664-4867

Email address: ke-sangyorenkei@city.yokohama.jp

Return to the previous page

Page ID: 215-563-429

Menu

  • LINE
  • Twitter
  • Facebook
  • Instagram
  • YouTube
  • SmartNews